Cargando…
Role of tumor gene mutations in treatment response to immune checkpoint blockades
Early studies shed light on the immune suppression of immune checkpoint molecules in the cancer microenvironment, with later studies applying immune checkpoint blockade (ICB) in treatment of various malignancies. Despite the encouraging efficacy of ICBs in a substantial subset of cancer patients, th...
Autores principales: | Wang, Manni, Yu, Liu, Wei, Xiawei, Wei, Yuquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985804/ https://www.ncbi.nlm.nih.gov/pubmed/35692451 http://dx.doi.org/10.1093/pcmedi/pbz006 |
Ejemplares similares
-
Deletion of the RNA-editing enzyme ADAR1A: new strategy to potentiate responses to PD-1 immune checkpoint blockade
por: Wang, Manni, et al.
Publicado: (2019) -
Coronavirus in human diseases: Mechanisms and advances in clinical treatment
por: Lin, Panpan, et al.
Publicado: (2020) -
The role of neoantigen in immune checkpoint blockade therapy
por: Yi, Ming, et al.
Publicado: (2018) -
Predictive biomarkers for tumor immune checkpoint blockade
por: Tong, Mengting, et al.
Publicado: (2018) -
Mitochondrial DNA in the regulation of innate immune responses
por: Fang, Chunju, et al.
Publicado: (2015)